SHAREHOLDER ALERT: Weiss Law Reminds RMED, CYBE, LTRY, and TMX Shareholders About Its Ongoing Investigations
NEW YORK, Sept. 22, 2022 /PRNewswire/ --
If you own shares in any of the companies listed above and
would like to discuss our investigations or have any questions concerning
this notice or your rights or interests, please contact:
Joshua Rubin, Esq.
Weiss Law
305 Broadway, 7th Floor
New York, NY 10007
(212) 682-3025
(888) 593-4771
[email protected]
Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors Ra Medical Systems, Inc. (NYSE: RMED) in connection with the proposed merger of the Company with Catheter Precision, Inc. ("Catheter Precision"). The Merger is structured as a stock for stock reverse merger whereby all of Catheter Precision's outstanding convertible promissory notes and equity interests are to be exchanged for shares of RMED common stock and Catheter Precision options assumed by RMED. If you own RMED shares and wish to discuss this investigation or your rights, please call us or visit our website: https://www.weisslaw.co/news-and-cases/rmed
Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of CyberOptics Corporation (NASDAQ: CYBE) in connection with the proposed acquisition of CYBE by Nordson Corporation. Pursuant to the merger agreement, CYBE shareholders will receive $54.00 in cash for each share of CYBE common stock owned. If you own CYBE shares and wish to discuss this investigation or your rights, please call us or visit our website: https://www.weisslaw.co/news-and-cases/cybe
Weiss Law is investigating possible breaches of fiduciary duty and violations of the federal securities laws by the Board of Directors and certain Company officers of Lottery.com Inc. (NASDAQ: LTRY) relating to: (i) an admitted lack of adequate internal controls and procedures over financial reporting, including the failure to report entry into to a line of credit, failure to properly recognize revenue and the reporting of cash, and the inability to continue as a going concern; and (ii) noncompliance with state and federal laws governing the sale of lottery tickets. If you own LTRY shares and wish to discuss this investigation or your rights, please call us or visit our website: https://www.weisslaw.co/news-and-cases/ltry
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Terminix Global Holdings, Inc. (NYSE: TMX), in connection with the proposed acquisition of TMX by Rentokil Initial plc ("Rentokil Initial"). Pursuant to the merger agreement, TMX shareholders will receive approximately 643.29 million new Rentokil Initial shares (representing approximately 128.66 million American depository shares ("ADSs"), based on a 1:5 ADS to Rentokil Initial share ratio) and approximately $1.3 billion in cash. If you own TMX shares and wish to discuss this investigation or your rights, please call us or visit our website: https://www.weisslaw.co/news-and-cases/tmx
SOURCE Weiss Law
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article